EGFR and pancreatic neoplasm: ROS-activated PKD1 stimulates transcription factors NF-κB1 and NF-κB2, which up-regulate the expression of EGFR and its ligands TGFα and EGF, thus inducing EGFR/KrasWT signaling cascade and, consequently, pancreatic cancer proliferation and malignant progression [93].